It is a pharma private limited company based in Kolkata, West Bengal, India, established in 1987.
1987 | Kolkata, West Bengal, India | ActiveBewell Pharmaceuticals Pvt Ltd, a active private limited company, was established on 08 September 1987 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U27201WB1987PTC042976. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.96 M.
It upholds a compliant status. Its leadership includes Sangeeta Sadani (Director), Krishna Kumar Sadani (Additional Director). Past directors included Sangeeta Sadani, Santu Malakar, Soumitra Dutta. It holds no open charges and ₹16.79 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at P-599, Keyatala Road,, Kolkata, West Bengal, 700029.
U27201WB1987PTC042976
042976
08 September 1987
₹1.00 M
₹0.96 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Bewell Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sangeeta Sadani | Director | 01 Sep 2015 | Current |
| Krishna Kumar Sadani | Additional Director | 01 Sep 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 01 Sep 2015 | Past |
| Pramod Abcsdd | Director | 01 Sep 2015 | Past |
| Pramod Abcsdd | Director | 10 May 2010 | Past |
| Pramod Abcsdd | Director | 15 Jun 2016 | Past |
| Pramod Abcsdd | Director | 04 Feb 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bewell Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 22.15% increase in profit. The company's net worth dipped by a decrease of 3.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Bewell Pharmaceuticals had a public holding of 11.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹167,901,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jun 2011 | State Bank Of India | ₹12.45 Cr | Satisfied |
| 13 Oct 2010 | Allahabad Bank | ₹3.34 Cr | Satisfied |
| 16 Jun 2005 | State Bank Of India | ₹10.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Bewell Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bewell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bewell Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bewell Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge registered on 03 Jun 2011 via Charge ID 10290507 with State Bank Of India was fully satisfied on 20 Sep 2024. was completed.
Bewell Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was recorded as a recent event.
Progress on Sangeeta Sadani was appointed as a Director was appointed as a Director on 01 Sep 2015 & has been associated with this company since 10 years 2 months . was documented.
The activity Krishna Kumar Sadani was appointed as a Additional Director was appointed as a Additional Director on 01 Sep 2015 & has been associated with this company since 10 years 2 months . was completed.
A charge with State Bank Of India of Rs. 124.47 M registered on 03 Jun 2011 with Charge ID 10290507 was modified on 15 Jan 2014. was recorded as a recent event.
The CIN of Bewell Pharmaceuticals Pvt Ltd is U27201WB1987PTC042976.
Bewell Pharmaceuticals Pvt Ltd is headquartered at P-599, Keyatala Road,, Kolkata, West Bengal, 700029.
Bewell Pharmaceuticals Pvt Ltd was incorporated on 08 September 1987.
The current directors of Bewell Pharmaceuticals Pvt Ltd are
The primary industry of Bewell Pharmaceuticals Pvt Ltd is Trade.
Bewell Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Bewell Pharmaceuticals Pvt Ltd is ₹1.00 M, and the paid-up capital is ₹0.96 M.
The compliance status of Bewell Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX